Efficacy and Safety of Gefitinib in Patients with Advanced Head and Neck Squamous Cell Carcinoma: A Meta-Analysis of Randomized Controlled Trials

Figure 2

Risk of bias. (a) Risk of bias graph based on the Cochrane “Risk of bias” tool. (b) Risk of bias summary based on the Cochrane “Risk of bias” tool.

(a)

(b)